JPWO2022085739A1 - - Google Patents

Info

Publication number
JPWO2022085739A1
JPWO2022085739A1 JP2022557590A JP2022557590A JPWO2022085739A1 JP WO2022085739 A1 JPWO2022085739 A1 JP WO2022085739A1 JP 2022557590 A JP2022557590 A JP 2022557590A JP 2022557590 A JP2022557590 A JP 2022557590A JP WO2022085739 A1 JPWO2022085739 A1 JP WO2022085739A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022557590A
Other languages
Japanese (ja)
Other versions
JP7423815B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022085739A1 publication Critical patent/JPWO2022085739A1/ja
Application granted granted Critical
Publication of JP7423815B2 publication Critical patent/JP7423815B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2022557590A 2020-10-20 2021-10-20 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム Active JP7423815B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020176062 2020-10-20
JP2020176062 2020-10-20
PCT/JP2021/038825 WO2022085739A1 (ja) 2020-10-20 2021-10-20 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム

Publications (2)

Publication Number Publication Date
JPWO2022085739A1 true JPWO2022085739A1 (https=) 2022-04-28
JP7423815B2 JP7423815B2 (ja) 2024-01-29

Family

ID=81289782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022557590A Active JP7423815B2 (ja) 2020-10-20 2021-10-20 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム

Country Status (2)

Country Link
JP (1) JP7423815B2 (https=)
WO (1) WO2022085739A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011233066A (ja) * 2010-04-30 2011-11-17 Huma Corp 被験者募集方法、仲介者のサーバ、ソフトウェア、記録媒体
JP2019513504A (ja) * 2016-02-12 2019-05-30 バレンタイン,エドマンド,エル. 安全性および有効性プロフィールが向上したオピオイド+デバイス組合せ製品
WO2019191464A1 (en) * 2018-03-30 2019-10-03 Eli Lilly And Company Methods of treating ulcerative colitis
JP2019529479A (ja) * 2016-09-30 2019-10-17 アレクシオン ファーマシューティカルズ, インコーポレイテッド 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011233066A (ja) * 2010-04-30 2011-11-17 Huma Corp 被験者募集方法、仲介者のサーバ、ソフトウェア、記録媒体
JP2019513504A (ja) * 2016-02-12 2019-05-30 バレンタイン,エドマンド,エル. 安全性および有効性プロフィールが向上したオピオイド+デバイス組合せ製品
JP2019529479A (ja) * 2016-09-30 2019-10-17 アレクシオン ファーマシューティカルズ, インコーポレイテッド 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法
WO2019191464A1 (en) * 2018-03-30 2019-10-03 Eli Lilly And Company Methods of treating ulcerative colitis

Also Published As

Publication number Publication date
WO2022085739A1 (ja) 2022-04-28
JP7423815B2 (ja) 2024-01-29

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
JPWO2022085739A1 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220930

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20221026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231113

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240117

R150 Certificate of patent or registration of utility model

Ref document number: 7423815

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150